Daily funding roundup - Dec. 18th, 2020

WorkWhile has raised $3.5M; MetaCX landed $7.5M; PostHog secured $12M; Foresight picks up $15M

Walnut: Walnut is a New York-based codeless, customizable platform that's aiming to help sales reps to "own their successful sales demo experience". Walnut has raised $3.5 million infunding from SV Angel, A.Capital, NFX and numerous individuals, including Joe Montana and former a16z partners. The company has now raised $6 million. Read more 

WorkWhile: WorkWhile is a San Francisco-based labor platform for hourly workers. WorkWhile has raised $3.5 million in seed funding led by Khosla Ventures, with participation from F7 and numerous individual investors, including Stitch Fix CEO Katrina Lake and longtime VC Jennifer Fonstad. Read more

Avenue 8: Avenue 8 is a San Francisco-based residential brokerage platform that aims to enable agents to be more entrepreneurial. Avenue 8 has raised $4 million in seed funding led by Craft Ventures, which was joined by Zigg Capital and Good Friends (a fund whose investors include the founders of Warby Parker, Harry's and Allbirds). Read more

Tap Network: Tap Network is a New York-based startup focused on corporate rewards programs. Tap Network has raised $4 million in funding from investors, including Revelis Capital, Nima Capital, the Forbes family office, Warner Music Group, Access Industries, and longtime VC Bill Tai. Read more

MetaCX: MetaCX is an Indianapolis, In.-based platform that helps suppliers and buyers of enterprise software to communicate and collaborate. MetaCX has raised $7.5 million co-led by Greenspring Associates and BIP Capital. The company has now raised $24.5 million altogether. Read more

PostHog: PostHog is a San Francisco-based open source product analytics platform. PostHog has raised $12 million in Series A funding led by GV, with participation from YC Continuity Fund. Read more

Foresight: Foresight is a San Francisco-based insurtech startup centered around workers with more hazardous jobs. Foresight  raised $15 million funding earlier this year, including from Blackhorn Ventures and Transverse Insurance Group. Altogether, it has raised $20.5 million from investors, including Brick and Mortar Ventures and Builders VC. Read more

Neurogene: Neurogene is a New York-based company developing genetic medicines to treat people with inherited neurological diseases like Batten disease. Neurogene has raised $115 million in Series B funding. EcoR1 Capital led the round, joined by BlackRock, Janus Henderson Investors, Casdin Capital, Avidity Partners, Ascendant BioCapital, Arrowmark Partners, Alexandria Venture Investments and earlier backers Redmile Group, Samsara BioCapital and Cormorant Asset Management. Read more

Verily: Verily is a South San Francisco-based life sciences research and engineering organization spun out of Alphabet. Verily has raised $700 million from earlier backers, including Alphabet, Silver Lake, Temasek and the Ontario Teachers’ Pension Plan. Read more

If you are interested in being included in our funding roundup, submit your press release or blog post about your financing round to kristin@vator.tv. If you want a longer write-up, please do give us a couple of days heads up. If you'd like to be included in our Today's Entrepreneur column, please send me your Vator profile.

Image by Arek Socha from Pixabay